1Y Annualised Return
▲67.67%
3Y Annualised Return
▲46.81%
5Y Annualised Return
▲47.27%
10Y Annualised Return
▲18.50%
Fortis Healthcare Stock Performance
|
|
|
Fortis Healthcare Company background
Fortis Healthcare Overview
Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.
Fortis Healthcare Business Segments and Revenue Model
Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.
Fortis Healthcare Key Milestones
- 1996: Incorporated and launched its first hospital in Mohali, Punjab
- 2005: Acquired Escorts Heart and Research Centre in Delhi
- 2007: Launched its IPO and got listed on BSE and NSE
- 2015: Fortis Hospital Noida won the National Energy Conservation Award
- 2015: Received the Golden Globe Tigers Award for patient safety initiatives
- 2018: Founders resigned amid financial issues; IHH Healthcare acquired a 31.1% stake
- 2019: Acquired RHT Health Trust assets worth approximately ₹4,650 crore
- 2023: Completed acquisition of Medeor Hospital in Manesar
- 2024: Announced acquisition of a 31% stake in Agilus Diagnostics
- 2025: Won seven International Medical Value Travel Awards for excellence in various specialties
Fortis Healthcare ESG and Sustainability
- Tracks energy and water usage across hospitals with 19 active efficiency initiatives
- Focuses on eco-friendly biomedical waste management and carbon footprint reduction
- Implements WHO surgical safety protocols to enhance patient care
- Each unit has designated ESG champions driving sustainable practices
- Long-term goal includes embedding sustainability into core operations by 2030
Fortis Healthcare Awards and Recognitions
- Won the Golden Globe Tigers Award for excellence in patient safety practices
- Received the National Energy Conservation Award for energy efficiency at the Noida hospital
- Honoured at the International Patient Safety Conference for innovation and leadership
- Secured seven awards at the Medical Value Travel Summit across key specialties like cardiology, oncology, and orthopaedics
Fortis Healthcare Financial Highlights
Fortis Healthcare Share Price Today
Over the past
Fortis Healthcare Fundamental
Market Cap (in crs)
67,081.81
Face Value
10
Turnover (in lacs)
18,438.98
Key Metrics
Fortis Healthcare Key Financials
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
2331.44 Cr | 2166.72 Cr | 2007.2 Cr | 1928.26 Cr | 1988.39 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
7849.69 Cr | 6931.17 Cr | 6359.35 Cr | 5744.95 Cr | 4076.68 Cr | 4684.96 Cr |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
325.14 Cr | 263.86 Cr | 183.38 Cr | 252.24 Cr | 188.85 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
797.86 Cr | 635.71 Cr | 611.15 Cr | 765.8 Cr | -103.73 Cr | 79.32 Cr |
Fortis Healthcare Result Highlights
Result Summary
-
Fortis Healthcare Ltd reported a 7.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 17.6%.
-
Its expenses for the quarter were up by 5.9% QoQ and 16.1% YoY.
-
The net profit increased 23.3% QoQ and increased 70.3% YoY.
-
The earnings per share (EPS) of Fortis Healthcare Ltd stood at 4.26 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Fortis Healthcare Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,201.00 | 1,03,539.33 | 6001 | 8099.5 | 7,184.00 | -1.66% | -7.80% | 5.05% | -0.43% | 47.82% | 0.18% | 73.84 | 85.54 | 11.11 | |
1,937.60 | 39,596.95 | 1255.1 | 2370.2 | 1,955.20 | -0.70% | 5.86% | 11.36% | 47.18% | 155.76% | 0.23% | 85.12 | 85.54 | 17.05 | |
653.25 | 33,846.26 | 387.1 | 732.2 | 655.45 | -1.86% | -5.14% | 12.08% | 34.87% | 179.76% | 0.74% | 100.12 | 85.54 | 7.72 | |
1,083.90 | 1,05,438.47 | 940.05 | 1314.3 | 1,086.00 | -6.71% | -4.79% | -5.63% | 1.85% | 142.21% | 0.14% | 151.84 | 85.54 | 12.40 | |
706.55 | 28,271.82 | 474.05 | 798.4 | 706.85 | 3.38% | -1.44% | 5.69% | 16.11% | 135.60% | 0.00% | 99.45 | 85.54 | 12.34 | |
1,200.80 | 32,276.35 | 996.45 | 1456.5 | 1,212.40 | -3.94% | -3.88% | 0.33% | 3.30% | 162.50% | 0.00% | 61.41 | 85.54 | 8.50 |
Fortis Healthcare Share Price FAQs
What is Share Price of Fortis Healthcare ?
Fortis Healthcare share price is ₹888.55 in NSE and ₹888.05 in BSE as on 4/12/2025.
How has Fortis Healthcare shares performed in the past ?
Fortis Healthcare share price in the past 1-year return was 24.98. The Fortis Healthcare share hit a 1-year low of Rs. 577 and a 1-year high of Rs. 1104.3.
What is the market cap of Fortis Healthcare ?
The market cap of Fortis Healthcare is Rs. 67081.81 Cr. as of 4/12/2025.
What is the current P/E ratio of Fortis Healthcare ?
The PE ratios of Fortis Healthcare is 362.47 as of 4/12/2025.
What is the current PB ratio of Fortis Healthcare ?
The PB ratios of Fortis Healthcare is 7.3 as of 4/12/2025
What is the Mutual Fund shareholding in Fortis Healthcare ?
The Mutual Fund Shareholding in Fortis Healthcare was 24.92% at the end of 4/12/2025.
How to buy Fortis Healthcare shares?
You can easily buy Fortis Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Fortis Healthcare ?
The 52-week high and low of Fortis Healthcare share price is ₹1104.3 and ₹577 as of 4/12/2025.
What is the EPS of Fortis Healthcare ?
The earnings per share (EPS) of Fortis Healthcare stood at 4.26 during Q2 FY 2025-26.
Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.